Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.
Aguiar C, Alegria E, Bonadonna RC, Catapano AL, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Ferrari R. Aguiar C, et al. Among authors: millan j. Atheroscler Suppl. 2015 Sep;19:1-12. doi: 10.1016/S1567-5688(15)30001-5. Atheroscler Suppl. 2015. PMID: 26315511
[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].
Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, González-Santos P, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X; en nombre del Foro de la Dislipemia Aterogénica. Brea A, et al. Among authors: millan j. Clin Investig Arterioscler. 2016 Nov-Dec;28(6):295-301. doi: 10.1016/j.arteri.2016.06.001. Epub 2016 Sep 5. Clin Investig Arterioscler. 2016. PMID: 27609708 Spanish.
[Chronic kidney disease and dyslipidaemia].
Pascual V, Serrano A, Pedro-Botet J, Ascaso J, Barrios V, Millán J, Pintó X, Cases A. Pascual V, et al. Among authors: millan j. Clin Investig Arterioscler. 2017 Jan-Feb;29(1):22-35. doi: 10.1016/j.arteri.2016.07.004. Epub 2016 Nov 15. Clin Investig Arterioscler. 2017. PMID: 27863896 Review. Spanish.
Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.
Ascaso JF, Millán J, Hernández-Mijares A, Blasco M, Brea Á, Díaz Á, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica de la SEA. Ascaso JF, et al. Among authors: millan j. Clin Investig Arterioscler. 2017 Mar-Apr;29(2):86-91. doi: 10.1016/j.arteri.2016.11.001. Epub 2017 Feb 6. Clin Investig Arterioscler. 2017. PMID: 28185675 English, Spanish.
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.
Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Catapano AL. Ferrari R, et al. Among authors: millan j. Eur Heart J Suppl. 2016 Apr 12;18(Suppl C):C2-C12. doi: 10.1093/eurheartj/suw009. Eur Heart J Suppl. 2016. PMID: 28533705
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias.
Pedro-Botet J, Ascaso JF, Blasco M, Brea Á, Díaz Á, Hernández-Mijares A, Pintó X, Millán J; Grupo de trabajo sobre Dislipidemia Aterogénica, Sociedad Española de Arteriosclerosis. Pedro-Botet J, et al. Among authors: millan j. Clin Investig Arterioscler. 2020 Sep-Oct;32(5):209-218. doi: 10.1016/j.arteri.2019.12.003. Epub 2020 Feb 6. Clin Investig Arterioscler. 2020. PMID: 32037300 English, Spanish.
1,129 results